Beijing Yuanda Biotechnology Group

Beijing Yuanda Biopharmaceutical Co., Ltd., a subsidiary of China Grand Enterprises, is a high-tech enterprise specializing in the research, development, and manufacturing of genetic engineering drugs. Established in 1994, the company is a pioneer in China's biotechnology sector, particularly known for its production of recombinant human growth hormone (rhGH) and recombinant human erythropoietin (rhEPO). With a focus on endocrinology and nephrology, Beijing Yuanda operates large-scale GMP-certified manufacturing facilities in the Beijing Economic-Technological Development Area. Their portfolio primarily addresses pediatric growth disorders and anemia associated with chronic renal failure. The company maintains a robust sales and distribution network across China, positioning itself as a key player in the domestic biologics market.